Santhera Pharmaceuticals Holding AG Stock Xetra
Stocks
S3F
CH0027148649
Pharmaceuticals
OTC Markets Traded| Market Cap | 235M 290M 255M 220M 412M 27.39B 421M 2.82B 1.09B 13.54B 1.09B 1.07B 46.94B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 262M 325M 285M 246M 461M 30.63B 470M 3.15B 1.22B 15.14B 1.22B 1.19B 52.48B | EV / Sales 2026 * |
2.77x | EV / Sales 2027 * | 2.22x |
| Free-Float |
81.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Santhera Pharmaceuticals Holding AG
| Manager | Title | Age | Since |
|---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 58 | 2019-11-30 |
Catherine Isted
DFI | Director of Finance/CFO | 51 | 2025-02-23 |
Marc Schrader
COO | Chief Operating Officer | 55 | 2022-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Meier
CHM | Chairman | 64 | 2022-06-29 |
| Director/Board Member | 58 | 2017-04-03 | |
Bradley Meyer
BRD | Director/Board Member | 47 | 2023-06-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -0.62% | - | - | 290M | |
| +2.56% | +12.99% | +63.21% | +13.78% | 318B | |
| -0.92% | +9.59% | +30.45% | -4.55% | 72.22B | |
| +3.20% | +9.35% | +42.70% | +115.15% | 8.89B | |
| -0.43% | +0.43% | +2.99% | -6.70% | 8.25B | |
| -6.43% | -4.71% | -9.79% | -0.60% | 4.23B | |
| -6.42% | +5.27% | +2.08% | +22.34% | 3.58B | |
| -6.87% | -12.75% | -34.90% | +19.59% | 3.23B | |
| +4.67% | +5.54% | +50.13% | +54.13% | 2.72B | |
| -4.41% | +5.98% | +9.57% | -22.65% | 2.03B | |
| Average | -1.50% | +2.78% | +17.38% | +21.17% | 46.99B | |
| Weighted average by Cap. | +1.66% | +11.47% | +53.67% | +12.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 94.7M 117M 103M 88.66M 166M 11.05B 170M 1.14B 440M 5.46B 440M 430M 18.94B | 116M 143M 125M 108M 203M 13.49B 207M 1.39B 537M 6.67B 537M 525M 23.11B |
| Net income | - | - |
| Net Debt | 27.7M 34.27M 30.05M 25.93M 48.63M 3.23B 49.64M 333M 129M 1.6B 129M 126M 5.54B | 21.4M 26.48M 23.22M 20.03M 37.57M 2.5B 38.35M 257M 99.53M 1.23B 99.43M 97.25M 4.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
